Sun Pharma Q4 profit halves to Rs 636 cr on distribution strategy change
Sales in the US were $443 million for the quarter, a 20 per cent increase over the same period last year, and accounted for 44 per cent of total sales
Sales in the US were $443 million for the quarter, a 20 per cent increase over the same period last year, and accounted for 44 per cent of total sales http://bit.ly/2WbN9AL May 28, 2019 at 09:49AM
Sales in the US were $443 million for the quarter, a 20 per cent increase over the same period last year, and accounted for 44 per cent of total sales http://bit.ly/2WbN9AL May 28, 2019 at 09:49AM
Comments
Post a Comment